3 studies found for:    15972865 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC)
Condition: Lung Cancer
Intervention: Drug: BIBW 2992 (Afatinib)
2 Unknown  Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Vinorelbine
3 Completed Vinorelbine Plus Cisplatin or No Further Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Surgically Removed
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: vinorelbine ditartrate

Indicates status has not been verified in more than two years